Temporal Changes in the Use of Drug-Eluting Stents for Patients With Non–ST-Segment–Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention From 2006 to 2008
Matthew T. Roe(Clinical Research Institute), Eric D. Peterson(The University of Texas Southwestern Medical Center), Christopher P. Cannon(Brigham and Women's Hospital), Ralph G. Brindis, Lloyd W. Klein(University of California, San Francisco), Anita Y. Chen(University of Rochester Medicine), John Rumsfeld(American Heart Association), E. Magnus Ohman(Duke University), David J. Magid(Regions Hospital), W. Brian Gibler(University of Cincinnati), Sunil V. Rao(New York University)
Cited by 45
Related Papers
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
|Journal of the American College of Cardiology|2014|3.6k
An Updated Definition of Stroke for the 21st Century
|Stroke|2013|3.5k
Mayo Clinic Proceedings
|Mayo Clinic Proceedings|2000|2.2k